SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-20-015284
Filing Date
2020-11-02
Accepted
2020-11-02 17:21:03
Documents
66
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q espr-20200930.htm   iXBRL 10-Q 1188222
2 EX-31.1 espr-ex311x09302020.htm EX-31.1 13375
3 EX-31.2 espr-ex312x09302020.htm EX-31.2 14647
4 EX-32.1 espr-ex321x09302020.htm EX-32.1 12071
  Complete submission text file 0001628280-20-015284.txt   5561727

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT espr-20200930.xsd EX-101.SCH 47206
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT espr-20200930_cal.xml EX-101.CAL 64581
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT espr-20200930_def.xml EX-101.DEF 203433
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT espr-20200930_lab.xml EX-101.LAB 531757
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT espr-20200930_pre.xml EX-101.PRE 331928
10 EXTRACTED XBRL INSTANCE DOCUMENT espr-20200930_htm.xml XML 861635
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35986 | Film No.: 201281330
SIC: 2834 Pharmaceutical Preparations